Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Casadevall

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Current Opinion in Microbiology|September 6, 2000
Recent progress in understanding host-fungal interactionsA Casadevall
Expert Opinion on Investigational Drugs|July 5, 2005
Antibody-based therapies as anti-infective agentsA Casadevall
Revista Iberoamericana De Micologia|March 1, 1997
Antibodies and fungi: an evolving paradigm with opportunities for the development of new antifungal therapies and vaccinesA Casadevall
Trends in Microbiology|May 16, 1998
Antibody-mediated protection against intracellular pathogensA Casadevall
Clinical Immunology (Orlando, Fla.)|September 25, 1999
Passive antibody therapies: progress and continuing challengesA Casadevall
Infection and Immunity|November 1, 1995
Antibody immunity and invasive fungal infectionsA Casadevall
Emerging Infectious Diseases|July 1, 1996
Antibody-based therapies for emerging infectious diseasesA Casadevall
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1996
Crisis in infectious diseases: time for a new paradigm?A Casadevall
Annals of Epidemiology|May 20, 1998
Cryptococcosis in AlabamaA Casadevall
The Journal of Infectious Diseases|July 10, 2001
Host-pathogen interactions: the attributes of virulenceA Casadevall, L Pirofski
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Current Opinion in Microbiology|September 6, 2000
Recent progress in understanding host-fungal interactionsA Casadevall
Expert Opinion on Investigational Drugs|July 5, 2005
Antibody-based therapies as anti-infective agentsA Casadevall
Revista Iberoamericana De Micologia|March 1, 1997
Antibodies and fungi: an evolving paradigm with opportunities for the development of new antifungal therapies and vaccinesA Casadevall
Trends in Microbiology|May 16, 1998
Antibody-mediated protection against intracellular pathogensA Casadevall
Clinical Immunology (Orlando, Fla.)|September 25, 1999
Passive antibody therapies: progress and continuing challengesA Casadevall
Infection and Immunity|November 1, 1995
Antibody immunity and invasive fungal infectionsA Casadevall
Emerging Infectious Diseases|July 1, 1996
Antibody-based therapies for emerging infectious diseasesA Casadevall
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1996
Crisis in infectious diseases: time for a new paradigm?A Casadevall
Annals of Epidemiology|May 20, 1998
Cryptococcosis in AlabamaA Casadevall
The Journal of Infectious Diseases|July 10, 2001
Host-pathogen interactions: the attributes of virulenceA Casadevall, L Pirofski
Pageof 22